In Brief: FDA Fights for Access; ARI Idled; ICH, PIC/S and EU Launch Initiatives
This article was originally published in The Gold Sheet
Executive Summary
What happens now when plants block FDA inspections; how ARI drug shortage collaboration is falling short; how ICH is reforming; what PIC/S deems a deficiency; and how EU is updating the role of the QP.